Investment accounts
Adult accounts
Child accounts
Choosing Fidelity
Choosing Fidelity
Why invest with us Current offers Fees and charges Open an account Transfer investments
Financial advice & support
Fidelity’s Services
Fidelity’s Services
Financial advice Retirement Wealth Management Investor Centre (London) Bereavement
Guidance and tools
Guidance and tools
Choosing investments Choosing accounts ISA calculator Retirement calculators
Share dealing
Choose your shares
Tools and information
Tools and information
Share prices and markets Chart and compare shares Stock market news Shareholder perks IPOs and placings
Pensions & retirement
Pensions, tax & tools
Saving for retirement
Approaching / In retirement
Approaching / In retirement
Speak to a specialist Creating a retirement plan Taking tax-free cash Pension drawdown Annuities Investing in retirement Investment Pathways
Plant Health Care fungicide gets Mexico registration
(Sharecast News) - Crop peptide developer Plant Health Care announced the registration of its novel fungicide 'SAORI' in Mexico on Wednesday, for commercial launch. The AIM-traded firm said SAORI represented a breakthrough in fungicide technology, offering farmers a novel mode of action to combat detrimental plant diseases such as late blight, downy mildew and grey mould, as part of an integrated disease control program.
Scheduled for launch at the end of the third quarter, PHC said SAORI would be made available through key distributors for farmers cultivating berries, grapes, cucumbers, tomatoes, and other solanaceous and cucurbitaceous crops in Mexico.
It described SAORI as a broad-spectrum biological fungicide, presenting a novel mode of action for controlling fungal and bacterial plant pathogens across various agricultural crops.
PHC said a significant advantage of SAORI was its safety for both growers and farm workers, alongside exemption from maximum residue limit (MRL) restrictions, facilitating access to high-value export markets.
Initial claims on SAORI's product label included control of grey mould in berries and grapes, downy mildew in cucurbits like cucumbers, and late blight in tomatoes and other solanaceae crops, with additional claims on various crops and phytopathogens anticipated in the future.
Considering Mexico's substantial agricultural landscape, with 55,000 hectares dedicated to berries, 48,000 hectares to tomatoes, 150,000 hectares to peppers, and 60,000 hectares to potatoes, PHC said SAORI held promise for enhancing productivity across the sectors.
Mexico is the world's largest cucumber exporter, with production expected to reach 1.02 million metric tonnes by 2026.
The board said the burgeoning plant-applied biopesticides market in Mexico, estimated at $200m in 2022 and growing at a compound annual growth rate of 14.3%, offered a conducive environment for SAORI's commercial success.
SAORI's approval in Mexico involved submission to the Federal Committee for Protection from Sanitary Risks (COFEPRIS) in September last year.
That process entailed a review of safety and performance data, including replicated small plot field trials to validate efficacy.
"The smooth approval process was completed well ahead of forecast and validates all the hard work undertaken by the Company to submit a comprehensive data package demonstrating the safety and efficacy of SAORI," said chief executive officer Jeff Tweedy.
"As the 11th largest global food producer, Mexico provides a tremendous opportunity for the adoption of SAORI to support sustainable agriculture."
Tweedy said that, building on the current success of the company's ProAct biostimulant, its team in Mexico was already laying the groundwork to get SAORI into the hands of farmers later in the year.
"The approval of SAORI supports the company's vision to be a leading global provider of alternatives to conventional synthetic agrochemicals.
"We are excited about the developing plans to launch SAORI in 2024, with strong growth thereafter."
At 1332 GMT, shares in Plant Health Care were up 4.43% at 3.9p.
Reporting by Josh White for Sharecast.com.
Share this article
Related Sharecast Articles
Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.
Award-winning online share dealing
Search, compare and select from thousands of shares.
Expert insights into investing your money
Our team of experts explore the world of share dealing.
Policies and important information
Accessibility | Conflicts of interest statement | Consumer Duty Target Market | Consumer Duty Value Assessment Statement | Cookie policy | Diversity and Inclusion | Doing Business with Fidelity | Fidelity gender pay report | Investing in Fidelity funds | Legal information | Modern slavery | Mutual respect policy | Privacy statement | Remuneration policy | Security | Statutory and Regulatory disclosures | Whistleblowing policy
Please remember that past performance is not necessarily a guide to future performance, the performance of investments is not guaranteed, and the value of your investments can go down as well as up, so you may get back less than you invest. When investments have particular tax features, these will depend on your personal circumstances and tax rules may change in the future. This website does not contain any personal recommendations for a particular course of action, service or product. You should regularly review your investment objectives and choices and, if you are unsure whether an investment is suitable for you, you should contact an authorised financial adviser. Before opening an account, please read the ‘Doing Business with Fidelity’ document which incorporates our client terms. Prior to investing into a fund, please read the relevant key information document which contains important information about the fund.
This website is issued by Financial Administration Services Limited, which is authorised and regulated by the Financial Conduct Authority (FCA) (FCA Register number 122169) and registered in England and Wales under company number 1629709 whose registered address is Beech Gate, Millfield Lane, Lower Kingswood, Tadworth, Surrey, KT20 6RP.